XTX Topco’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
Other funds holding VTGN
XTX Topco's VTGN Position: Q3 2026 in Review
XTX Topco reduced its VistaGen Therapeutics (VTGN) stake by 63% in Q3 2026, selling an estimated $19K and leaving 43,462 shares worth $13.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3790.
XTX Topco first reported a position in VTGN in Q1 2022 and has held it in 6 quarters since. The position peaked at $247K in Q3 2025. 42 funds tracked by Wall St. Rank hold VTGN as of Q3 2026.
- XTX Topco held 43,462 shares of VistaGen Therapeutics worth $13.4K as of Q3 2026.
- XTX Topco sold 74,918 VistaGen Therapeutics shares in Q3 2026, an estimated $19K.
- VistaGen Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q3 2026, its #3790 holding.
- XTX Topco first reported a position in VistaGen Therapeutics in Q1 2022 and has held it in 6 quarters since.
- XTX Topco's VistaGen Therapeutics position peaked at $247K in Q3 2025.
- 42 funds tracked by Wall St. Rank held VistaGen Therapeutics as of Q3 2026.
Based on XTX Topco's 13F filing for Q3 2026, filed 16 Nov 2026.